| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1794401 | F | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | 91,504 | assay format | PubChem BioAssays | |||
| 2. | ALA2094261 | F | MMV: Screen against Mtb, single point, non replicating, at 25uM | Mycobacterium tuberculosis | 399 | organism-based format | MMV Malaria Box | ||
| 3. | ALA2094262 | F | MMV: Screen against Mtb, single point, replicating, at 25uM | Mycobacterium tuberculosis | 399 | organism-based format | MMV Malaria Box | ||
| 4. | ALA2094263 | F | MMV: CRC and MIC90 against Mtb (non replicating) | Mycobacterium tuberculosis | 55 | organism-based format | MMV Malaria Box | ||
| 5. | ALA2094264 | F | MMV: CRC and MIC90 against Mtb (replicating) | Mycobacterium tuberculosis | 56 | organism-based format | MMV Malaria Box | ||
| 6. | ALA2094265 | T | MMV: Cytotoxicity CRC and LD50 against HepG2 | Homo sapiens | 57 | cell-based format | MMV Malaria Box | ||
| 7. | ALA2114775 | F | PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) | 75,092 | assay format | PubChem BioAssays | |||
| 8. | ALA2028070 | F | MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration. | Plasmodium falciparum | 315 | organism-based format | MMV Malaria Box | ||
| 9. | ALA2028071 | F | MMV: Inhibition of Plasmodium falciparum 3D7 (EC50). | Plasmodium falciparum | 317 | organism-based format | MMV Malaria Box | ||
| 10. | ALA2028072 | F | MMV: Inhibition of Plasmodium falciparum K1 (EC50). | Plasmodium falciparum | 171 | organism-based format | MMV Malaria Box | ||
| 11. | ALA2028073 | F | MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro). | Trypanosoma cruzi | 400 | organism-based format | MMV Malaria Box | ||
| 12. | ALA2028074 | F | MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro). | Trypanosoma brucei brucei | 400 | organism-based format | MMV Malaria Box | ||
| 13. | ALA2028075 | F | MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro). | Trypanosoma brucei rhodesiense | 400 | organism-based format | MMV Malaria Box | ||
| 14. | ALA2028076 | F | MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro. | Leishmania infantum | 400 | organism-based format | MMV Malaria Box | ||
| 15. | ALA2028077 | T | MMV: Cytotoxicity against human fibroblasts (MRC-5) cells. | Homo sapiens | 400 | cell-based format | MMV Malaria Box | ||
| 16. | ALA1794553 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | Homo sapiens | 58,172 | cell-based format | PubChem BioAssays | ||
| 17. | ALA1794580 | F | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 130,890 | organism-based format | PubChem BioAssays | ||
| 18. | ALA1040691 | F | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | organism-based format | Novartis Malaria Screening | ||
| 19. | ALA1040692 | F | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | organism-based format | Novartis Malaria Screening | ||
| 20. | ALA1040693 | T | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | Homo sapiens | 5,614 | cell-based format | Novartis Malaria Screening |
The page will load shortly, Thanks for your patience!